Clinical significance of C-Reactive Protein to Lymphocyte Count Ratio as a prognostic factor for Survival in Non-small Cell Lung Cancer Patients undergoing Curative Surgical Resection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Jae-Joon | - |
dc.contributor.author | Hur, Joon Young | - |
dc.contributor.author | Eo, Wankyu | - |
dc.contributor.author | An, Soomin | - |
dc.contributor.author | Kim, Dae Hyun | - |
dc.contributor.author | Lee, Sookyung | - |
dc.date.accessioned | 2021-07-05T00:41:07Z | - |
dc.date.available | 2021-07-05T00:41:07Z | - |
dc.date.created | 2021-07-01 | - |
dc.date.issued | 2021-05 | - |
dc.identifier.issn | 1837-9664 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/81585 | - |
dc.description.abstract | Purpose: We assessed the clinical feasibility of C-reactive protein to lymphocyte ratio (CLR) as a determinant of survival in patients with non-small cell lung cancer (NSCLC) undergoing curative surgical resection. Methods: A retrospective study was conducted on patients with stage I and II NSCLC undergoing curative resection. Demographic and clinical variables, including CLR, were collected and analyzed. The Cox proportional hazards model was used to calculate hazard ratios for overall survival (OS) and cancer-specific survival (CSS). The Mann-Whitney U test was used to compare differences between two independent groups. Results: The median age of the patients was 69.0 years, and male patients comprised 63.9% of all patients. A total of 164 (75.9%) patients were categorized as having stage I disease and 52 (24.1%) as having stage II disease. Using the multivariate Cox model, age (hazard ratio [HR] 1.08, p>0.001), lymphatic invasion (HR 3.12, p=0.004), stage (HR 5.10, p<0.001), and CLR (HR 1.01, p=0.003) were significant determinants of OS. In addition, age (HR 1.11, p=0.002), lymphatic invasion (HR 3.16, p=0.010), stage (HR 6.89, p>0.001), and CLR (HR 1.05, p=0.002) were significant determinants of CSS. Conclusions: Our findings show that CLR could be a determinant of survival in NSCLC patients undergoing curative surgical resection. © 2021 Ivyspring International Publisher. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IVYSPRING INT PUBL | - |
dc.relation.isPartOf | Journal of Cancer | - |
dc.title | Clinical significance of C-Reactive Protein to Lymphocyte Count Ratio as a prognostic factor for Survival in Non-small Cell Lung Cancer Patients undergoing Curative Surgical Resection | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000661280400006 | - |
dc.identifier.doi | 10.7150/JCA.58094 | - |
dc.identifier.bibliographicCitation | Journal of Cancer, v.12, no.15, pp.4497 - 4504 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85108565335 | - |
dc.citation.endPage | 4504 | - |
dc.citation.startPage | 4497 | - |
dc.citation.title | Journal of Cancer | - |
dc.citation.volume | 12 | - |
dc.citation.number | 15 | - |
dc.contributor.affiliatedAuthor | Hwang, Jae-Joon | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | C-Reactive Protein | - |
dc.subject.keywordAuthor | Carcinoma | - |
dc.subject.keywordAuthor | Lymphocyte Count | - |
dc.subject.keywordAuthor | Non-Small Cell Lung | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Pulmonary Surgical Procedures | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.